POZAVIO is a drug that targets a specific gene mutation in Non Small Cell Lung Cancer (NSCLC). The MOA of POZAVIO is that it binds to receptors within a difficult to reach “binding pocket” within the cancer cell.
The logo design illustrates the manner in which POZAVIO reaches places within the cell that other drugs simply cannot.
Full-color iteration.